
The parties are partnering up to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies

The parties are partnering up to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies

Advance purchase agreement is for up to 200 million doses of Nuvaxovid

Discussions will revolve around fortifying the pharma supply chain

Turnkey centers will promote scalable vaccine production for an end-to-end manufacturing network for mRNA-based vaccines in Africa

CDMO obtains both Vibalogics and Arranta Bio to increase presence in the sector

Will establish presence in Belgium, Denmark, Norway, the Netherlands, Poland and Sweden

Plans are underway to build Scottish fill-finish center, renovate API facility in England

Agreement provides pharma firms with an RWD and commercialization solution

Publication finds that only about 40% of retail pharmacists feel equipped to discuss biosimilars with patients

The solution is a combination of cold chain logistics, serialization compliance and distribution

Quris’s system can help predict clinical safety, AI firm notes

Software firm merges with PharmaLex Group

Collaboration, the companies note, is expected to further engage patients

USP study reveals urgency to make changes, with additional concerns coming to light amid times of crisis

Logistics provider’s investment will develop distribution area by an additional 27%

Acquisition expands Medable’s global engineering talent and gives company a third location in Europe

Branded as the Ember Cube, the container features reusability, real-time tracking and self-contained recharging of refrigerant

Grows Syner-G’s presence in RTP, a biotech hub that continues to develop

CDMO will use its BFS knowledge to support production out of its Kaysersberg, France plant

Acquires Medaxis, a patient engagement company

The latest people news happenings over the past month

Following a November FDA public meeting, HDA reiterates the objections it had to guidance FDA issued in mid-2021 under the Drug Supply Chain Security Act (DSCSA)

Merger with Phlexglobal expands provider’s technological capabilities

Rebrand reflects company’s plans to access to the US and Chinese markets

Expansion of the collaboration features a reduction in carbon dioxide emissions

Integrated system intends to accelerate enrollment by strengthening relationship between hub patient services and providers

Anticipated yearly production is 2 million units

In a civil action, Gilead alleges an extensive, transnational counterfeiting ring of HIV and other drugs

Partnership looks to ensure that chargebacks for suppliers are as accurate as possible